Almonertinib/Pemetrexed/Carboplatin in EGFR T790M+ Advanced Lung Cancer

Clinical trial NCT04592666 · UNKNOWN

Trial details

NCT number: NCT04592666
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer, Non-small Cell EGFR T790M EGFR Gene Mutation

Start date: 2020-10-09
Primary completion: 2021-12-31
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.